MedTrace Logo

Improve SCA Bridge Study

NCT03715790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1491

Last updated 2024-01-16

Study results available
· View outcomes & findings →

Summary

The purpose of the Improve SCA Bridge study is to characterize the care pathway flow of post-acute myocardial infarction (MI) patients as a result of standard assessments of left ventricular ejection fraction (LVEF) in the acute phase (≤14 days post- acute MI) and chronic phase (≥40-90 days post-acute MI).

Conditions

  • Sudden Cardiac Arrest
  • Acute Myocardial Infarction

Interventions

BEHAVIORAL

EP referred group

Referred for sudden cardiac death (SCD) risk stratification and management

BEHAVIORAL

Non-Referred group

Not referred for sudden cardiac death (SCD) risk stratification and management.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Shu Zhang · Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-02
Primary Completion
2021-04-16
Completion
2021-05-27

Countries

  • Bangladesh
  • Brunei
  • China
  • Egypt
  • India
  • Indonesia
  • Malaysia
  • Pakistan
  • Philippines
  • Saudi Arabia
  • Singapore
  • South Africa
  • South Korea
  • Taiwan
  • Thailand
  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03715790 on ClinicalTrials.gov